Martin Fan
Stock Analyst at Wedbush
(4.92)
# 193
Out of 4,692 analysts
58
Total ratings
83.3%
Success rate
83.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Martin Fan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RNAC Cartesian Therapeutics | Maintained: Buy | $38 | $9.28 | +309.48% | 7 | Aug 18, 2026 | |
| IMUX Immunic | Initiated Coverage: Buy | $45 | $15.80 | +184.81% | 1 | Aug 17, 2026 | |
| NKTR Nektar Therapeutics | Maintained: Hold | $80 | $71.38 | +12.08% | 4 | Aug 14, 2026 | |
| GETY Getty Images Holdings | Rated: Hold | n/a | $0.2431 | - | 1 | Aug 12, 2026 | |
| VOR Vor Biopharma | Maintained: Hold | $18 → $27 | $22.48 | +20.11% | 4 | Aug 12, 2026 | |
| ZURA Zura Bio | Maintained: Buy | $15 → $22 | $5.54 | +297.11% | 4 | Aug 12, 2026 | |
| SANA Sana Biotechnology | Reiterated: Buy | $7 | $3.87 | +80.88% | 5 | Aug 11, 2026 | |
| IMA ImageneBio | Maintained: Sell | $2 | $5.10 | -60.78% | 4 | Aug 6, 2026 | |
| TRAX First Tracks Biotherapeutics | Maintained: Buy | $30 → $60 | $41.84 | +43.40% | 3 | Jul 28, 2026 | |
| ARTV Artiva Biotherapeutics | Maintained: Buy | $40 | $11.30 | +253.98% | 3 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $2.39 | +192.89% | 4 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $6.05 | +65.29% | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $51.20 | -10.16% | 1 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 → $45 | $92.62 | -51.41% | 4 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $32.32 | +39.23% | 4 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $45 | $57.03 | n/a | 2 | Aug 7, 2025 |
Cartesian Therapeutics
Aug 18, 2026
Maintained: Buy
Price Target: $38
Current: $9.28
Upside: +309.48%
Immunic
Aug 17, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $15.80
Upside: +184.81%
Nektar Therapeutics
Aug 14, 2026
Maintained: Hold
Price Target: $80
Current: $71.38
Upside: +12.08%
Getty Images Holdings
Aug 12, 2026
Rated: Hold
Price Target: n/a
Current: $0.2431
Upside: -
Vor Biopharma
Aug 12, 2026
Maintained: Hold
Price Target: $18 → $27
Current: $22.48
Upside: +20.11%
Zura Bio
Aug 12, 2026
Maintained: Buy
Price Target: $15 → $22
Current: $5.54
Upside: +297.11%
Sana Biotechnology
Aug 11, 2026
Reiterated: Buy
Price Target: $7
Current: $3.87
Upside: +80.88%
ImageneBio
Aug 6, 2026
Maintained: Sell
Price Target: $2
Current: $5.10
Upside: -60.78%
First Tracks Biotherapeutics
Jul 28, 2026
Maintained: Buy
Price Target: $30 → $60
Current: $41.84
Upside: +43.40%
Artiva Biotherapeutics
May 21, 2026
Maintained: Buy
Price Target: $40
Current: $11.30
Upside: +253.98%
May 14, 2026
Maintained: Buy
Price Target: $7
Current: $2.39
Upside: +192.89%
May 8, 2026
Maintained: Buy
Price Target: $10
Current: $6.05
Upside: +65.29%
Feb 26, 2026
Reiterated: Buy
Price Target: $46
Current: $51.20
Upside: -10.16%
Jan 13, 2026
Maintained: Buy
Price Target: $42 → $45
Current: $92.62
Upside: -51.41%
Dec 22, 2025
Maintained: Buy
Price Target: $45
Current: $32.32
Upside: +39.23%
Aug 7, 2025
Maintained: Buy
Price Target: $40 → $45
Current: $57.03
Upside: n/a